Skip to main content
M

Mainz BioMed N.V. — Investor Relations & Filings

Ticker · MYNZ ISIN · NL0015000LC2 LEI · 894500XWJE7LIJNYQ547 F Manufacturing
Filings indexed 163 across all filing types
Latest filing 2026-04-28 Regulatory Filings
Country NL Netherlands
Listing F MYNZ

About Mainz BioMed N.V.

https://mainzbiomed.com/

Mainz BioMed N.V. is a molecular genetics diagnostics company that develops market-ready solutions for the early detection of life-threatening conditions, with a primary focus on cancer. The company's flagship product is ColoAlert, a user-friendly, non-invasive, at-home diagnostic test for colorectal cancer. This test combines stool-based DNA analysis with fecal immunochemical testing (FIT) to identify cancer indicators. In addition to its commercialized colorectal cancer screening test, Mainz BioMed is actively developing a portfolio of new diagnostic solutions, including genetic testing methods for pancreatic cancer, to transform cancer detection into prevention.

Recent filings

Filing Released Lang Actions
8-K - Quantum Cyber N.V. (0001874252) (Filer)
Regulatory Filings
2026-04-28 English
8-K - MAINZ BIOMED N.V. (0001874252) (Filer)
Regulatory Filings
2026-04-15 English
10-K - MAINZ BIOMED N.V. (0001874252) (Filer)
Annual Report FY 2025
2026-03-31 English
DEF 14A - MAINZ BIOMED N.V. (0001874252) (Filer)
Proxy Solicitation & Information Statement
2026-03-25 English
8-K - MAINZ BIOMED N.V. (0001874252) (Filer)
Regulatory Filings
2026-03-25 English
8-K - MAINZ BIOMED N.V. (0001874252) (Filer)
Regulatory Filings
2026-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.